A Study to Assess the Pharmacokinetics, Glucodynamics, Safety, and Tolerability of Single Subcutaneous Injections of Insulin Lispro With BioChaperone Excipient in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2014
At a glance
- Drugs Insulin lispro (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Adocia
- 29 Jul 2013 Primary endpoint 'Area-under-the-drug-concentration-time-curve, peak-drug-concentration and time-to-peak-drug-concentration' have been met, according to an Eli lilly media release.
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Aug 2012 Actual initiation date (Jul 2012) added as reported by ClinicalTrials.gov.